After a long campaign and many challenges, the Quebec chapter of the Canadian Hemophilia Society and the Canadian Hemophilia society have succeeded in making Hemlibra available to all non-inhibitor severe Hemophilia A patients, as well as all clinically severe cases irrespective of factor level threshold.
We congratulate them on their victory and look forward to working together to continue to increase access to Hemlibra for all people with Hemophilia A in Canada.
Please see the Canadian Hemophilia Society announcement here.
